Related Experiment Video

Updated: Jul 10, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Treatment after myocardial infarction

Wilbert S Aronow1

  • 1Department of Medicine, Division of Cardiology, New York Medical College, Valhalla, New York 10595, USA. wsaronow@aol.com

Comprehensive Therapy
|November 7, 2007
PubMed

Insights

Optimal management after myocardial infarction (MI) involves intensive treatment of modifiable risk factors. Key interventions include medications for hypertension and high cholesterol, and consideration of devices for sudden cardiac death prevention.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Preventive Cardiology

Background:

  • Secondary prevention after myocardial infarction (MI) is crucial for improving patient outcomes.
  • Modifiable risk factors significantly impact long-term prognosis post-MI.

Purpose of the Study:

  • To outline evidence-based strategies for the intensive management of patients following myocardial infarction.
  • To emphasize the importance of treating modifiable risk factors to reduce morbidity and mortality.

Main Methods:

  • Review of current guidelines and clinical evidence for post-MI care.
  • Focus on pharmacological interventions for hypertension, dyslipidemia, and diabetes.
  • Discussion of device therapy and revascularization strategies.

Main Results:

  • Specific treatment targets for blood pressure (<140/90 mmHg, <130/80 mmHg for diabetics/renal insufficiency) and LDL cholesterol (<70 mg/dl).
  • Recommendations for lifelong use of aspirin/clopidogrel, beta-blockers, and ACE inhibitors.
  • Indications for implantable cardioverter-defibrillators and coronary revascularization.

Conclusions:

  • Intensive management of modifiable risk factors is essential for patients post-MI.
  • Pharmacological therapy, device implantation, and revascularization should be tailored to individual patient risk and symptoms.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...